Route of Administration | Dapsone Dose | AUC0–24 h | AUC0–∞ | Cmax | tmax | t1/2 | % Bioavailability |
---|---|---|---|---|---|---|---|
ng · h/ml | ng · h/ml | ng/ml | h | h | |||
Intravenous1-a | 12 mg/kg | 37,741 | 38,323 | 10,474 | 4.27 | ||
Oral | 12 mg/kg | 29,296 | 29,947 | 4,890 | 1 | 4.38 | 78.1 |
Dermal (1% in 10% DGME) | 3 mg | 25.9 | 62.2 | 1.62 | 6 | 28.4 | 0.16 |
(12 mg/kg) | |||||||
Dermal (1% in 25% DGME) | 3 mg | 77.7 | 94.9 | 5.56 | 6 | 8.42 | 0.25 |
(12 mg/kg) | |||||||
Dermal (5% in 25% DGME) | 15 mg | 260.8 | 1,507 | 12.8 | 8 | 77.8 | 0.79 |
(60 mg/kg) |
↵1-a CL = 313 ml/h/kg andVss = 1582 ml/kg for single i.v. bolus dose.